PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-12.98%
Negative revenue growth while WEED.TO stands at 10.92%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-5.67%
Negative gross profit growth while WEED.TO is at 71.07%. Joel Greenblatt would examine cost competitiveness or demand decline.
-77.54%
Negative EBIT growth while WEED.TO is at 84.69%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-77.54%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-23.37%
Negative net income growth while WEED.TO stands at 81.19%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-11.75%
Negative EPS growth while WEED.TO is at 84.62%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-11.75%
Negative diluted EPS growth while WEED.TO is at 84.62%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
10.30%
Share reduction more than 1.5x WEED.TO's 21.85%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
10.30%
Diluted share reduction more than 1.5x WEED.TO's 21.85%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
-213.44%
Negative OCF growth while WEED.TO is at 68.82%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-293.67%
Negative FCF growth while WEED.TO is at 67.42%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
No Data
No Data available this quarter, please select a different quarter.
-49.02%
Negative 5Y CAGR while WEED.TO stands at 25.46%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-38.88%
Negative 3Y CAGR while WEED.TO stands at 43.99%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-73.69%
Negative 10Y OCF/share CAGR while WEED.TO stands at 15.32%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
63.22%
5Y OCF/share CAGR at 75-90% of WEED.TO's 83.25%. Bill Ackman would push for operational improvements to match competitor’s mid-term gains.
80.56%
3Y OCF/share CAGR similar to WEED.TO's 84.45%. Walter Schloss might see both benefiting from a rising tide or parallel expansions.
-1805.63%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-176.55%
Negative 5Y net income/share CAGR while WEED.TO is 26.50%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
51.73%
3Y net income/share CAGR 50-75% of WEED.TO's 95.79%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
9259.09%
10Y equity/share CAGR above 1.5x WEED.TO's 207.79%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
-35.28%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-58.67%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.30%
Our AR growth while WEED.TO is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
4.84%
We show growth while WEED.TO is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-1.69%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-8.28%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
0.29%
We have some new debt while WEED.TO reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-73.35%
Our R&D shrinks while WEED.TO invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-19.29%
We cut SG&A while WEED.TO invests at 245.39%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.